Cambridge Healthtech Institute’s 5th Annual

Clinical Biospecimens Technology and Outsourcing

Managing Specimens and Partnering with Labs & Biorepositories

February 20-21, 2020


The availability of high-quality biological specimens, laboratory access, and diagnostics services are of the utmost importance for biomarker-driven clinical trials and future research. The complexity and number of samples collected and analyzed during studies has increased steadily over the years and we need to come up with best practices, operational models, and IT solutions to deal with this volume and complexity. CHI’s 5th Annual Clinical Biospecimens and Central Lab Solutions conference brings together leading experts, clinical trial sponsors, and CROs to discuss challenges and identify actions to improve infrastructure for biomarker-driven clinical trials.

Arrive early and attend Part 1 (Wed - Thurs): Clinical Biomarkers Operations and Innovation

Preliminary Agenda

CLINICAL SPECIMEN MANAGEMENT IN THE ERA OF PRECISION MEDICINE

Challenges of Clinical Specimen Management in the Era of Precision Medicine

Debra Reinhard, Head, TM Enabling Solutions, Translational Medicine, Bristol-Myers Squibb Co.

Title to be Announced

Mohan Bangalore, PhD, MBA, Global Head BioAssets, Protein, Cellular & Structural Sciences (PCSS), Medicine Design, R&D, GlaxoSmithKline

Performing Research during a Clinical Trial: Managing the Biospecimens

Matthew Nguyen, Manager, Clinical Biospecimen Operations, BioMarin Pharmaceutical Inc.

Clinical Sample Vendor Qualification and Process Management

Mary Zuniga, Consultant, Translational Science, Immunology, Eli Lilly & Co.

TECHNOLOGY TO ADVANCE BIOMARKER AND BIOSPECIMEN MANAGEMENT

Biobanking Strategy Using Advanced Informatics to Enable Scientific Discovery and Innovation

Lynn Wetherwax, Senior Manager, BSM & Biobank, Research Operations, Amgen

Overview on Technologies and Approaches for Biospecimen Management

Brenda Yanak, Principal, Clinical Transformation Partners

MAKING VIRTUAL TRIAL REAL

The Connected Patient: A "One Stop Shop" for Trial Information and Data

Megan McBride, MPH, Associate Director, Janssen Clinical Innovation, GCDO, R&D, Janssen, The Pharmaceutical Companies of Johnson & Johnson

INTERACTIVE PANEL: Making Virtual Real: Taking Trials Forward

Moderator: Jane Myles, Head, Operational Intelligence and Innovation, Roche
Sharin Roth, Director, Clinical Pharmacology, Bioanalysis, Otsuka Pharmaceutical Companies
Bardia Akbari, PharmD, Senior Vice President, Clinical Operations, Science37

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Arrive early and attend Part 1 (Wed - Thurs): Clinical Biomarkers Operations and Innovation




For more details on the conference, please contact:
Marina Fishtinsky, MD

Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781.972.5496
Email: mfilshtinsky@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5457
Email: iquigley@healthtech.com

Companies L-Z
Patty Rose
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.1349
Email: prose@healthtech.com